Alexander S Zevin1, Lyle McKinnon, Adam Burgener, Nichole R Klatt. 1. aDepartment of Pharmaceutics, University of Washington bWashington National Primate Research Center, Seattle, Washington, USA cCentre for the AIDS Programme of Research (CAPRISA), Durban, South Africa dDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba eNational Laboratory for HIV Immunology, JC Wilt Infectious Disease Research Center, Public Health Agency of Canada, Winnipeg, Manitoba, Canada fDepartment of Medicine Solna, Center for Molecular Medicine, Karolinska Institute, Karolinska, Sweden.
Abstract
PURPOSE OF REVIEW: This article describes the mechanisms and consequences of both microbial translocation and microbial dysbiosis in HIV infection. RECENT FINDINGS: Microbes in HIV are likely playing a large role in contributing to HIV pathogenesis, morbidities and mortality. Two major disruptions to microbial systems in HIV infection include microbial translocation and microbiome dysbiosis. Microbial translocation occurs when the bacteria (or bacterial products) that should be in the lumen of the intestine translocate across the tight epithelial barrier into systemic circulation, where they contribute to inflammation and pathogenesis. This is associated with poorer health outcomes in HIV-infected individuals. In addition, microbial populations in the gastrointestinal tract are also altered after HIV infection, resulting in microbiome dysbiosis, which further exacerbates microbial translocation, epithelial barrier disruption, inflammation and mucosal immune functioning. SUMMARY: Altered microbial regulation in HIV infection can lead to poor health outcomes, and understanding the mechanisms underlying microbial dysbiosis and translocation may result in novel pathways for therapeutic interventions.
PURPOSE OF REVIEW: This article describes the mechanisms and consequences of both microbial translocation and microbial dysbiosis in HIV infection. RECENT FINDINGS: Microbes in HIV are likely playing a large role in contributing to HIV pathogenesis, morbidities and mortality. Two major disruptions to microbial systems in HIV infection include microbial translocation and microbiome dysbiosis. Microbial translocation occurs when the bacteria (or bacterial products) that should be in the lumen of the intestine translocate across the tight epithelial barrier into systemic circulation, where they contribute to inflammation and pathogenesis. This is associated with poorer health outcomes in HIV-infected individuals. In addition, microbial populations in the gastrointestinal tract are also altered after HIV infection, resulting in microbiome dysbiosis, which further exacerbates microbial translocation, epithelial barrier disruption, inflammation and mucosal immune functioning. SUMMARY: Altered microbial regulation in HIV infection can lead to poor health outcomes, and understanding the mechanisms underlying microbial dysbiosis and translocation may result in novel pathways for therapeutic interventions.
Authors: J F Vázquez-Castellanos; S Serrano-Villar; A Latorre; A Artacho; M L Ferrús; N Madrid; A Vallejo; T Sainz; J Martínez-Botas; S Ferrando-Martínez; M Vera; F Dronda; M Leal; J Del Romero; S Moreno; V Estrada; M J Gosalbes; A Moya Journal: Mucosal Immunol Date: 2014-11-19 Impact factor: 7.313
Authors: Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek Journal: J Infect Dis Date: 2011-01-20 Impact factor: 5.226
Authors: M A Poles; M Fuerst; I McGowan; J Elliott; A Rezaei; D Mark; P Taing; P A Anton Journal: Am J Gastroenterol Date: 2001-06 Impact factor: 10.864
Authors: Philip I Lee; Emily J Ciccone; Sarah W Read; Ava Asher; Robert Pitts; Daniel C Douek; Jason M Brenchley; Irini Sereti Journal: J Infect Dis Date: 2009-06-01 Impact factor: 5.226
Authors: Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis Journal: Science Date: 2011-09-01 Impact factor: 47.728
Authors: N R Klatt; J D Estes; X Sun; A M Ortiz; J S Barber; L D Harris; B Cervasi; L K Yokomizo; L Pan; C L Vinton; B Tabb; L A Canary; Q Dang; V M Hirsch; G Alter; Y Belkaid; J D Lifson; G Silvestri; J D Milner; M Paiardini; E K Haddad; J M Brenchley Journal: Mucosal Immunol Date: 2012-05-30 Impact factor: 7.313
Authors: Stefan Bereswill; André Fischer; Rita Plickert; Lea-Maxie Haag; Bettina Otto; Anja A Kühl; Javid I Dasti; Javid I Dashti; Andreas E Zautner; Melba Muñoz; Christoph Loddenkemper; Uwe Gross; Ulf B Göbel; Markus M Heimesaat Journal: PLoS One Date: 2011-06-15 Impact factor: 3.240
Authors: Ryan Brewster; Fiona B Tamburini; Edgar Asiimwe; Ovokeraye Oduaran; Scott Hazelhurst; Ami S Bhatt Journal: Trends Microbiol Date: 2019-06-06 Impact factor: 17.079
Authors: Aline Machiavelli; Rubens T Delgado Duarte; Maria M de Souza Pires; Carlos R Zárate-Bladés; Aguinaldo R Pinto Journal: Gut Microbes Date: 2019-01-18
Authors: Vanessa El Kamari; Carlee Moser; Corrilynn O Hileman; Judith S Currier; Todd T Brown; Liz Johnston; Peter W Hunt; Grace A McComsey Journal: Clin Infect Dis Date: 2019-04-08 Impact factor: 9.079
Authors: Stephanie M Dillon; Jon Kibbie; Eric J Lee; Kejun Guo; Mario L Santiago; Gregory L Austin; Sara Gianella; Alan L Landay; Andrew M Donovan; Daniel N Frank; Martin D McCARTER; Cara C Wilson Journal: AIDS Date: 2017-02-20 Impact factor: 4.177
Authors: Ryan R Cook; Jennifer A Fulcher; Nicole H Tobin; Fan Li; David Lee; Marjan Javanbakht; Ron Brookmeyer; Steve Shoptaw; Robert Bolan; Grace M Aldrovandi; Pamina M Gorbach Journal: AIDS Date: 2019-04-01 Impact factor: 4.177